All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
Powering insights from Cortellis. Link to Cortellis page on Clarivate website.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing the state of COVID-19 testing
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 28, 2021
See today's BioWorld Asia
Home
» Other news to note for Nov. 17, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for Nov. 17, 2020
Nov. 17, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abpro, Aikido, Altimmune, Amcure, Aravive, Astrazeneca, Atyr, Biontech, Biovaxys Technology, Bristol Myers Squibb, CCT Research, Collplant, CSL, Curevac, Farmacore, Guangzhou Baiyunshan, Hinova, Hitgen, Immuron, Johnson & Johnson, Kiadis, Lonza, Lung, Mallinckrodt, Nanoviricides, Noxopharm, Origimed, PDS, Pfizer, Pluristyx, Prestige, Qiagen, Recce, Reven, Selva, Sumitomo Dainippon, Sumitovant, Taiho, Takeda, Teva, Tscan, Urovant Sciences, Vaxart, Wuxi Advanced, Wuxi Apptec, Xoma, Xortx.
BioWorld Asia
Briefs
Other news to note